Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 453

1.
2.

BRAF V600E mutation analysis of thyroid nodules needle aspirates in relation to their ultrasongraphic classification: a potential guide for selection of samples for molecular analysis.

Nam SY, Han BK, Ko EY, Kang SS, Hahn SY, Hwang JY, Nam MY, Kim JW, Chung JH, Oh YL, Shin JH.

Thyroid. 2010 Mar;20(3):273-9. doi: 10.1089/thy.2009.0226.

PMID:
20187782
3.

Is follow-up BRAF(V600E) mutation analysis helpful in the differential diagnosis of thyroid nodules with negative results on initial analysis?

Yoon JH, Kim EK, Moon HJ, Kwak JY.

PLoS One. 2013;8(3):e58592. doi: 10.1371/journal.pone.0058592. Epub 2013 Mar 7.

4.

Diagnostic value of BRAF(V600E) mutation analysis of thyroid nodules according to ultrasonographic features and the time of aspiration.

Moon HJ, Kim EK, Chung WY, Choi JR, Yoon JH, Kwak JY.

Ann Surg Oncol. 2011 Mar;18(3):792-9. doi: 10.1245/s10434-010-1354-z. Epub 2010 Oct 14.

PMID:
20945104
5.

Cytomorphologic features in thyroid nodules read as "suspicious for malignancy" on cytology may predict thyroid cancers with the BRAF mutation.

Kwon HJ, Kim EK, Kwak JY.

Pathol Res Pract. 2015 Sep;211(9):671-6. doi: 10.1016/j.prp.2015.06.010. Epub 2015 Jul 2.

PMID:
26187369
6.

[Clinical role of BRAF V600E mutation testing in thyroid nodules].

Wan H, Zhang B, Wang Y, Xiao T, Guo H, Liu W, Yan D, Xu Z, Tang P.

Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2014 Jun;49(6):468-72. Chinese.

PMID:
25241863
7.
8.

Proper indication of BRAF(V600E) mutation testing in fine-needle aspirates of thyroid nodules.

Koh J, Choi JR, Han KH, Kim EK, Yoon JH, Moon HJ, Kwak JY.

PLoS One. 2013 May 24;8(5):e64505. doi: 10.1371/journal.pone.0064505. Print 2013.

9.

Incidence and predictive factors of inadequate fine-needle aspirates for BRAF(V600E) mutation analysis in thyroid nodules.

Lee KH, Kim HS, Han BK, Ko EY, Ki CS, Shin JH.

AJR Am J Roentgenol. 2014 Feb;202(2):391-6. doi: 10.2214/AJR.12.10291.

PMID:
24450682
10.

Surgical results of thyroid nodules according to a management guideline based on the BRAF(V600E) mutation status.

Kim SK, Hwang TS, Yoo YB, Han HS, Kim DL, Song KH, Lim SD, Kim WS, Paik NS.

J Clin Endocrinol Metab. 2011 Mar;96(3):658-64. doi: 10.1210/jc.2010-1082. Epub 2011 Jan 14.

PMID:
21239517
11.

A morpho-molecular diagnosis of papillary thyroid carcinoma: BRAF V600E detection as an important tool in preoperative evaluation of fine-needle aspirates.

Marchetti I, Lessi F, Mazzanti CM, Bertacca G, Elisei R, Coscio GD, Pinchera A, Bevilacqua G.

Thyroid. 2009 Aug;19(8):837-42. doi: 10.1089/thy.2009.0074.

PMID:
19534623
12.

Contribution of the BRAF mutation analysis in calcified thyroid nodules.

Yoo EY, Shin JH, Ko EY, Han BK.

AJR Am J Roentgenol. 2012 Apr;198(4):891-5. doi: 10.2214/AJR.11.6866.

PMID:
22451557
13.

Role of ultrasonographic/clinical profile, cytology, and BRAF V600E mutation evaluation in thyroid nodule screening for malignancy: a prospective study.

Rossi M, Buratto M, Bruni S, Filieri C, Tagliati F, Trasforini G, Rossi R, Beccati MD, Degli Uberti EC, Zatelli MC.

J Clin Endocrinol Metab. 2012 Jul;97(7):2354-61. doi: 10.1210/jc.2011-3494. Epub 2012 Apr 24.

PMID:
22535974
14.

The BRAF(V600E) mutation is associated with malignant ultrasonographic features in thyroid nodules.

Lee EJ, Song KH, Kim DL, Jang YM, Hwang TS, Kim SK.

Clin Endocrinol (Oxf). 2011 Dec;75(6):844-50. doi: 10.1111/j.1365-2265.2011.04154.x.

PMID:
21707687
15.

BRAFV600E mutation testing in fine needle aspirates of thyroid nodules: potential value of real-time PCR.

Kwak JY, Han KH, Yoon JH, Kim EK, Moon HJ, Kim YL, Park SJ, Choi JR.

Ann Clin Lab Sci. 2012 Summer;42(3):258-65.

PMID:
22964613
16.

Detection of BRAF c.1799T > A (p.V600E) mutation using residual routine fine-needle aspiration specimens of papillary thyroid carcinoma.

Zhao H, Zhang ZH, Zhou B, Xiao T, Pan QJ, Guo HQ.

Diagn Cytopathol. 2015 Oct;43(10):786-90. doi: 10.1002/dc.23302. Epub 2015 Jul 7.

PMID:
26152656
17.

Clinical implication of highly sensitive detection of the BRAF V600E mutation in fine-needle aspirations of thyroid nodules: a comparative analysis of three molecular assays in 4585 consecutive cases in a BRAF V600E mutation-prevalent area.

Lee ST, Kim SW, Ki CS, Jang JH, Shin JH, Oh YL, Kim JW, Chung JH.

J Clin Endocrinol Metab. 2012 Jul;97(7):2299-306. doi: 10.1210/jc.2011-3135. Epub 2012 Apr 12.

PMID:
22500044
18.

Detection of BRAFV600E mutation on fine needle aspiration specimens of thyroid nodule refines cyto-pathology diagnosis, especially in BRAF600E mutation-prevalent area.

Chung KW, Yang SK, Lee GK, Kim EY, Kwon S, Lee SH, Park DJ, Lee HS, Cho BY, Lee ES, Kim SW.

Clin Endocrinol (Oxf). 2006 Nov;65(5):660-6.

PMID:
17054470
19.

Uncommon BRAF mutations in the follicular variant of thyroid papillary carcinoma: New insights.

Rossi ED, Martini M, Bizzarro T, Capodimonti S, Cenci T, Lombardi CP, Pontecorvi A, Fadda G, Larocca LM.

Cancer Cytopathol. 2015 Oct;123(10):593-602. doi: 10.1002/cncy.21586. Epub 2015 Jul 31.

20.

Does addition of BRAF V600E mutation testing modify sensitivity or specificity of the Afirma Gene Expression Classifier in cytologically indeterminate thyroid nodules?

Kloos RT, Reynolds JD, Walsh PS, Wilde JI, Tom EY, Pagan M, Barbacioru C, Chudova DI, Wong M, Friedman L, LiVolsi VA, Rosai J, Lanman RB, Kennedy GC.

J Clin Endocrinol Metab. 2013 Apr;98(4):E761-8. doi: 10.1210/jc.2012-3762. Epub 2013 Mar 8.

PMID:
23476074

Supplemental Content

Support Center